Spastic paraplegia-Paget disease of bone syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:329475G11.4
Who is this for?
Show terms as
1Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spastic paraplegia-Paget disease of bone syndrome is an extremely rare genetic condition that combines two distinct problems affecting the body. The first is hereditary spastic paraplegia, which causes progressive stiffness and weakness in the legs due to damage to the nerve fibers (upper motor neurons) that control leg movement. Over time, walking becomes increasingly difficult. The second component is Paget disease of bone, a condition where the normal process of bone renewal becomes disrupted, leading to bones that are enlarged, misshapen, and weakened. This can cause bone pain, fractures, and joint problems, most commonly affecting the pelvis, spine, skull, and long bones of the legs. Patients typically develop progressive difficulty walking due to leg stiffness and spasticity, along with bone pain and skeletal deformities from the Paget disease component. Some individuals may also develop dementia or other cognitive changes. This syndrome has been linked to mutations in the VCP gene (valosin-containing protein), which plays an important role in protein processing within cells. Mutations in this gene can also cause a broader condition known as multisystem proteinopathy, which can affect muscles, bones, brain, and motor neurons in various combinations. There is currently no cure for this syndrome. Treatment focuses on managing symptoms from both conditions. Spasticity may be treated with physical therapy, stretching, and medications such as baclofen or tizanidine. Paget disease of bone is typically managed with bisphosphonate medications, which help regulate bone turnover. A multidisciplinary team approach is essential for optimal care.

Key symptoms:

Progressive leg stiffness and spasticityDifficulty walking that worsens over timeBone pain, especially in the pelvis, spine, or legsEnlarged or misshapen bonesIncreased risk of bone fracturesMuscle weakness in the legsBalance problemsJoint pain and stiffnessDifficulty with bladder controlCognitive decline or dementia in some casesMuscle wastingFatigueHearing loss if skull bones are affected

Clinical phenotype terms (15)— hover any for plain English
EMG: neuropathic changesHP:0003445Increased spinal bone densityHP:0004563Abnormal skeletal morphologyHP:0011842Tongue fasciculationsHP:0001308Limb fasciculationsHP:0007289
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2021Natural History Study of Patients With VCP-related Disease

Nationwide Children's Hospital

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Spastic paraplegia-Paget disease of bone syndrome.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Natural History Study of Patients With VCP-related Disease
Active
PI: Lindsay Alfano (Nationwide Children's Hospital) · Sites: Columbus, Ohio · Age: 1899 yrs

No specialists are currently listed for Spastic paraplegia-Paget disease of bone syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spastic paraplegia-Paget disease of bone syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spastic paraplegia-Paget disease of bone syndromeForum →

No community posts yet. Be the first to share your experience with Spastic paraplegia-Paget disease of bone syndrome.

Start the conversation →

Latest news about Spastic paraplegia-Paget disease of bone syndrome

No recent news articles for Spastic paraplegia-Paget disease of bone syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific VCP mutation do I have, and what does it mean for my prognosis?,How quickly is the spasticity likely to progress, and what can we do to slow it down?,Should I be screened for other conditions related to VCP mutations, such as muscle disease or dementia?,What medications are best for managing my bone disease and spasticity?,Should my family members be tested for this genetic mutation?,Are there any clinical trials or research studies I could participate in?,What physical therapy program would be most helpful for maintaining my mobility?

Common questions about Spastic paraplegia-Paget disease of bone syndrome

What is Spastic paraplegia-Paget disease of bone syndrome?

Spastic paraplegia-Paget disease of bone syndrome is an extremely rare genetic condition that combines two distinct problems affecting the body. The first is hereditary spastic paraplegia, which causes progressive stiffness and weakness in the legs due to damage to the nerve fibers (upper motor neurons) that control leg movement. Over time, walking becomes increasingly difficult. The second component is Paget disease of bone, a condition where the normal process of bone renewal becomes disrupted, leading to bones that are enlarged, misshapen, and weakened. This can cause bone pain, fractures,

How is Spastic paraplegia-Paget disease of bone syndrome inherited?

Spastic paraplegia-Paget disease of bone syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Spastic paraplegia-Paget disease of bone syndrome typically begin?

Typical onset of Spastic paraplegia-Paget disease of bone syndrome is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Spastic paraplegia-Paget disease of bone syndrome?

Yes — 1 recruiting clinical trial is currently listed for Spastic paraplegia-Paget disease of bone syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.